abnormal cardiovascular development_Efnb2<tm1.1Henk>/Efnb2<tm1.1Henk>

http://metadb.riken.jp/0002925E129orI129C57BL6orI129CD1Efnb2tm11HenkEfnb2tm11HenkEfnb2tm11Henk

abnormal cardiovascular development_Efnb2<tm1.1Henk>/Efnb2<tm1.1Henk>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• ephrin B2
  http://metadb.riken.jp/db/mgi_rdf/MGI:105097

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Efnb2<tm1.1Henk>/Efnb2<tm1.1Henk>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Efnb2<tm1.1Henk>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• either: 129 or (involves: 129 * C57BL/6) or (involves: 129 * CD-1)

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal cardiovascular development
  http://purl.obolibrary.org/obo/MP_0002925

文献

http://purl.org/net/cito/citesAsAuthority

• Chad A. Cowan, et.al., Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development., Developmental biology, 2004, 271
  http://rdf.ncbi.nlm.nih.gov/pubmed/15223333